Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02105441
Other study ID # 13-009050
Secondary ID
Status Completed
Phase
First received April 2, 2014
Last updated April 4, 2018
Start date March 2014
Est. completion date March 2018

Study information

Verified date April 2018
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Do adults and children over 7 years of age with unilateral or assymetric hearing loss benefit from cochlear implantation on the worst hearing side.


Description:

Unilateral hearing loss is known to impair binaural hearing abilities. Specifically, localization, speech understanding in noise, and binaural squelch suffer due to lack of binaural timing and level cues. This study is designed to examine how binaural hearing is improved following cochlear implantation on the impaired side. The study endpoints are collected at 6 months and 12 months post activation of the implant.

This is not a funded study. All costs are billed through insurance for reimbursement. There is an insurance approval process that we move through after a participant has been evaluated at the Mayo Clinic and found to be a candidate for cochlear implantation.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 7 Years and older
Eligibility Adults

- 18 years of age or older,

- Hearing loss in the ear to be implanted must such that speech understanding is not possible with a well fitted hearing aid. Specifically, less than 40% monosyllabic word understanding when that ear is tested in the best-aided condition and the other ear is sufficiently occluded or masked.

- Onset of hearing loss in the adult group must be post-lingual (after three years of age)

Children

- Children 7 years of age and older

- Hearing loss in the ear to be implanted configured such that word understanding is less 40% in the best aided condition

- Onset of hearing loss in the pediatric group must be post-lingual (after three years of age)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cochlear implant
Implantable hearing device

Locations

Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Listening Effort A dual task performance paradigm will be used in which both the primary task and the secondary task will be performed simultaneously. The primary task will consist of speech recognition testing in varying levels of background noise and quiet, whereas the secondary task will consist of a motor reaction to a randomly presented light one year post operative test time